Moreover, high expression of TIP30 was closely associated with a good OS of tumor patients in the subgroups based on sample size (more than 110 or less than 110), and the pooled HRs were 0.68 (95% CI: 0.51–0.91) and 0.48 (95% CI: 0.38–0.61), respectively. The gene discussed is HTATIP2; the disease is neoplasm.